Something Will Cause Inflation This Year, Not Oil Prices
As 2026 unfolds, inflation isn’t powered by oil alone. This report explains why something will cause inflation throug...
When Should I Start Investing For Retirement
Understanding when to start investing for retirement is crucial for financial security. Explore our insights for effective planning.
24,831 articles
Current Price March 2026: Oil Holds Near $91 Brent
Oil prices hover near $91 per barrel on March 11, 2026, with Brent at about $90.96. Analysts say supply discipline an...
Anthropic Just Sued Pentagon: The AI Race and Markets
Two new lawsuits filed by Anthropic target the Department of Defense, arguing for stricter controls on how its Claude...
Adobe (ADBE) 2026 Earnings Outlook, Growth Strategies
Adobe is navigating a fast-changing software landscape in 2026. This guide breaks down the 2026 earnings outlook, key...
U.S. Lifts Sanctions on Russian Oil, Markets React
The U.S. temporarily eases sanctions on Russian oil loaded on tankers for 30 days, aiming to calm markets amid Middle...
Oracle Just Posted Best Quarter; 2026 Could Get Even Better
Oracle just posted best quarter in years, powered by cloud and AI demand. This article breaks down what changed, why ...
Funko (FNKO) 2025 Earnings: Revenue Growth and Outlook
Fans and investors alike crave clarity on Funko's 2025 earnings. This guide breaks down revenue streams, margin dynam...
Powell Says the Economy Is Amazing, but Uncertainty Remains
Fed chair Powell kept policy steady as he hailed resilience in the U.S. economy, while warning that inflation and ene...
While World Watches Prices, Fed Cushion Near Empty for Crypto
Bitcoin traders grapple with a tightening macro backdrop as the Fed's liquidity cushion shrinks, signaling tighter fu...
What Strategy’s Products? From STRK to STRC Explained
Strategy unveils a three-part security lineup to fund bitcoin acquisitions, expanding access to crypto exposure while...
Chewy Just Popped. Stock: Buy Now or Wait for Gains
Chewy just popped. stock momentum followed a better-than-expected 2026 outlook, even as Q4 growth stayed modest. This...
Phathom Pharma Upgraded by Barclays to Overweight $18 Target
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status